Applying a Novel Approach to Modulating
NMDA Receptors to Develop Improved CNS Therapies
-
Overview:
-
Naurex is applying its novel chemistries to discover and develop compounds that modulate the NMDA receptor in a new way.
Learn more…
-
Our Mission:
Naurex is developing its novel GFPA drug platform and programs to treat multiple CNS diseases including depression, cognitive disorders, schizophrenia and neuropathic pain.
Learn more…
First clinical target: Treatment-resistant depression
